F45-13942-22801
5 vaccinations
9 coded responses
57 check-ins
9 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 920 / CA
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
-
2021-01-04
Survey response — days 1–6 daily, dose 1MedDRA: Pain in extremity, Swelling — Feeling: Good · Site: Pain, SwellingFree text: The mild arm pain was essentially resolved yesterday, but today I noticed a mild pruritic type pain that is new. Mild swelling also, without induration or erythema.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-05
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-01-12
- 2021-01-19
-
2021-01-26
Dose 2 — Moderna
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Lymphadenopathy, Pain — Feeling: Good · Site: Pain, Redness, SwellingFree text: Axillary lymphadenopathy with redness and pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Swelling · FeverFree text: Left axillary adenopathy is slightly improved. Still tender but redness has resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · HeadacheFree text: Left axillary adenopathy is improvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Improving left axillary adenopathy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-04-27
- 2021-07-27
-
2021-11-12
Dose 3 — Moderna
-
2021-11-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2022-02-11
-
2022-04-14
Dose 4 — Moderna
- 2022-04-14
-
2022-04-15
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2022-04-16
Survey response — days 1–6 daily, dose 4MedDRA: Axillary pain — Feeling: Good · Site: Pain, SwellingFree text: Pain in axilla ipsilateral to injection site. No palpable nodes.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-17
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, SwellingFree text: Tender 4cm node ipsilateral axilla.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-18
- 2022-04-19
- 2022-04-20
- 2022-04-21
- 2022-04-28
-
2022-05-19
Survey response — day 35, dose 4MedDRA: Malaise, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: FairFree text: Sore throat. Malaise. No fever. Covid test negative today.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Survey response — 3 months, dose 4MedDRA: COVID-19, Fatigue, Oropharyngeal pain — Feeling: GoodFree text: Got Covid in mid May. Mild sore throat and fatigue only. Fatigue has persisted slightly.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-29
Dose 5 — Pfizer-BioNTech
- 2022-10-13
- 2022-10-13
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-12-29
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-11-12 | Moderna | No |
| 4 | 2022-04-14 | Moderna | No |
| 5 | 2022-09-29 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): The mild arm pain was essentially resolved yesterday, but today I noticed a mild pruritic type pain that is new. Mild swelling also, without induration or erythema.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary lymphadenopathy with redness and pain.
Systemic reaction (other): Left axillary adenopathy is slightly improved. Still tender but redness has resolved.
Systemic reaction (other): Left axillary adenopathy is improving
Systemic reaction (other): Improving left axillary adenopathy.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Pain in axilla ipsilateral to injection site. No palpable nodes.
Systemic reaction (other): Tender 4cm node ipsilateral axilla.
Release 11 — day 35, dose 4
Symptoms: Sore throat. Malaise. No fever. Covid test negative today.
Release 12 — 3 months, dose 4
Symptoms: Got Covid in mid May. Mild sore throat and fatigue only. Fatigue has persisted slightly.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release